| | |
RR of death - CI at 95% (*)
|
|---|
| | |
MEN
|
WOMEN
|
|---|
|
ALICANTE
|
|
Age
|
00-49
|
1
|
1
|
|
50-64
|
8.2 (7.0-9.7)
|
7.1 (6.0-8.4)
|
|
65-74
|
34.2 (29.6-39.5)
|
21.1 (18.1-24.7)
|
|
Period
|
96-99
|
1
|
1
|
|
00-03
|
0.9 (0.8-1.0)
|
0.8 (0.7-0.9)
|
|
04-07
|
0.8 (0.7-0.9)
|
0.7 (0.6-0.8)
|
|
SES
|
SES1
|
1
|
1
|
|
SES2
|
1.3 (1.0-1.6)
|
1.4 (1.1-1.8)
|
|
SES3
|
1.5 (1.1-1.9)
|
1.8 (1.3-2.4)
|
|
CASTELLÓN
|
|
Age
|
00-49
|
1
|
1
|
|
50-64
|
8.4 (6.7-10.5)
|
6.3 (5.0-7.9)
|
|
65-74
|
34.2 (27.9-41.9)
|
21.9 (17.8-27.0)
|
|
Period
|
96-99
|
1
|
1
|
|
00-03
|
0.7 (0.6-0.8)
|
0.8 (0.6-0.9)
|
|
04-07
|
0.7 (0.6-0.8)
|
0.8 (0.7-0.9)
|
|
SES
|
SES1
|
1
|
1
|
|
SES2
|
1.3 (0.9-1.7)
|
1.1 (0.8-1.6)
|
|
SES3
|
1.4 (0.9-2.1)
|
1.7 (1.1-2.6)
|
|
VALENCIA
|
|
Age
|
00-49
|
1
| |
|
50-64
|
8.3 (7.6-9.1)
|
(**)
|
|
65-74
|
29.8 (27.4-32.4)
| |
|
Period
|
96-99
|
1
|
1
|
|
00-03
|
0.9 (0.8-0.9)
|
0.8 (0.8-0.9)
|
|
04-07
|
0.8 (0.7-0.8)
|
0.7 (0.7-0.8)
|
|
SES
|
SES1
|
1
| |
|
SES2
|
1.2 (1.1-1.3)
|
(**)
|
|
SES3
|
1.4 (1.2-1.6)
| |
|
(**) 00-49
|
SES1
| |
1
|
|
SES2
| |
1.1 (0.9-1.5)
|
|
SES3
| |
0.9 (0.6-1.3)
|
|
(**) 50-64
|
SES1
| |
1
|
|
SES2
| |
1.3 (1.0-1.6)
|
|
SES3
| |
1.8 (1.3-2.4)
|
|
(**) 65-74
|
SES1
| |
1
|
|
SES2
| |
1.2 (1.0-1.4)
|
| |
SES3
| |
1.5 (1.2-1.8)
|
- (*) In bold, RR are statistically significant at 95%.
- (**) Owing to the existence of significant interaction between age and SES for women, the RRs for the SES are shown in each of the age groups.
